Search & Filter All Posts

Filter

Series

Results for KDIGO Connections

(15 Results)
KDIGO Connections

KDIGO Connections: ADPKD in Kidney Transplant Candidates

Kidney transplant donors and autosomal dominant polycystic kidney disease.

T. David Bourne, MD renal pathologist and neuropathologist at arkana laboratories
By David Bourne, MD
KDIGO Connections

KDIGO Connections: MGRS

KDIGO offers some future directions for studying MGRS lesions.  

T. David Bourne, MD renal pathologist and neuropathologist at arkana laboratories
By David Bourne, MD
KDIGO Connections

KDIGO Connections: Fibrillary Glomerulopathy

If you have taken care of patients with fibrillary glomerulopathy, what has been the outcome?      

T. David Bourne, MD renal pathologist and neuropathologist at arkana laboratories
By David Bourne, MD
KDIGO Connections

KDIGO Connections: SLE and TMA

Remember to think about TMA lesions in your patients with lupus!  

T. David Bourne, MD renal pathologist and neuropathologist at arkana laboratories
By David Bourne, MD
KDIGO Connections

KDIGO Connections: Lupus Nephritis Treatment and Definitions

How do you initially treat patients with active lupus nephritis?  

T. David Bourne, MD renal pathologist and neuropathologist at arkana laboratories
By David Bourne, MD
KDIGO Connections

KDIGO Connections: Contrast Induced AKI

Management guidelines and “contrasting” opinion regarding contrast-associated acute kidney injury (AKI).  

T. David Bourne, MD renal pathologist and neuropathologist at arkana laboratories
By David Bourne, MD
KDIGO Connections

KDIGO Connections: Membranous Diagnosis Algorithm

Have you seen the latest proposed KDIGO algorithm for the diagnosis and treatment of membranous glomerulopathy? Dr. Bourne brings us…

T. David Bourne, MD renal pathologist and neuropathologist at arkana laboratories
By David Bourne, MD
KDIGO Connections

KDIGO Connections: HCV-Associated Kidney Disease

How do you treat patients with hepatitis C-associated kidney disease?

T. David Bourne, MD renal pathologist and neuropathologist at arkana laboratories
By David Bourne, MD
KDIGO Connections

KDIGO Connections: Atypical Hemolytic-Uremic Syndrome

How do you treat patients with atypical hemolytic-uremic syndrome? Learn more about treatment and atypical hemolytic-uremic syndrome through KDIGO Connections!…

T. David Bourne, MD renal pathologist and neuropathologist at arkana laboratories
By David Bourne, MD
KDIGO Connections

KDIGO Connections: ANCA Refactory

How do you manage your patients who have refractory ANCA-related glomerulonephritis?  

T. David Bourne, MD renal pathologist and neuropathologist at arkana laboratories
By David Bourne, MD
KDIGO Connections

KDIGO Connections: Minimal Change Disease

Do you treat minimal change disease in adults the same way?

T. David Bourne, MD renal pathologist and neuropathologist at arkana laboratories
By David Bourne, MD
KDIGO Connections

KDIGO Connections: Secondary IgA Nephropathy

Learn about secondary IgA nephropathy. IgA depositions has been associated with many conditions including infections, cirrhosis, and others.

T. David Bourne, MD renal pathologist and neuropathologist at arkana laboratories
By David Bourne, MD
KDIGO Connections

KDIGO Connections: Crescentic IgA Nephropathy

How do you treat Crescentic IgA Nephropathy? Learn how to define which stage the patient is in and what treatments…

T. David Bourne, MD renal pathologist and neuropathologist at arkana laboratories
By David Bourne, MD
KDIGO Connections

KDIGO Connections: PLA2R-Positive Membranous Glomerulonephritis

KDIGO has some recommendations for anti-PLA2R testing in the research setting, but do you follow anti-PLA2R levels in your patients…

T. David Bourne, MD renal pathologist and neuropathologist at arkana laboratories
By David Bourne, MD
KDIGO Connections

KDIGO Connections: Membranous Glomerulopathy

Welcome to the first post in our new series KDIGO Connections, a series in which we are asking our nephrologist…

T. David Bourne, MD renal pathologist and neuropathologist at arkana laboratories
By David Bourne, MD